Clover Health Investments (NASDAQ:CLOV) Lifted to “Hold” at Zacks Investment Research


Share on StockTwits

Clover Health Investments (NASDAQ:CLOV) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Tuesday, Zacks.com reports.

According to Zacks, “Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif. “

CLOV has been the subject of several other reports. Citigroup lowered their price target on Clover Health Investments from $19.00 to $13.00 in a report on Wednesday, March 3rd. JPMorgan Chase & Co. started coverage on Clover Health Investments in a report on Monday, February 1st. They issued a “neutral” rating and a $15.00 price target for the company. Finally, Credit Suisse Group started coverage on Clover Health Investments in a report on Monday, March 15th. They set a “neutral” rating and a $10.00 price objective for the company.

Shares of Clover Health Investments stock traded down $0.23 during trading hours on Tuesday, hitting $9.06. The company’s stock had a trading volume of 9,903,161 shares, compared to its average volume of 23,459,098. Clover Health Investments has a 12 month low of $6.31 and a 12 month high of $17.45. The stock has a 50 day moving average of $8.40 and a 200 day moving average of $10.87.

Several large investors have recently bought and sold shares of CLOV. Virtu Financial LLC bought a new position in shares of Clover Health Investments during the third quarter worth about $341,000. Advisory Services Network LLC bought a new position in Clover Health Investments in the fourth quarter valued at approximately $232,000. Valeo Financial Advisors LLC bought a new position in Clover Health Investments in the fourth quarter valued at approximately $205,000. Edge Wealth Management LLC bought a new position in Clover Health Investments in the first quarter valued at approximately $76,000. Finally, FNY Investment Advisers LLC bought a new position in Clover Health Investments in the first quarter valued at approximately $83,000. Institutional investors and hedge funds own 49.05% of the company’s stock.

About Clover Health Investments

Clover Health Investments, Corp. operates as a Medicare Advantage insurer in the United States. The company through its software platform provides preferred provider organization and health maintenance organization health plans for Medicare-eligible consumers. Clover Health Investments, Corp. was founded in 2012 and is headquartered in Franklin, Tennessee.

Recommended Story: G-20

Get a free copy of the Zacks research report on Clover Health Investments (CLOV)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.